Camille Laturno

Camille Laturno has over 20 years of experience in the legal field, with a focus on healthcare and pharmaceutical law. Camille has held various leadership positions, including Vice President of Commercial Product Law and Chief Privacy Officer at Global Blood Therapeutics since 2018. Prior to that, they worked as a Healthcare Law Attorney at Genentech from 2016 to 2018. From 2010 to 2015, Laturno served as the Associate General Counsel and Chief Privacy Officer at Onyx Pharmaceuticals, Inc., an Amgen subsidiary. Camille also has experience at companies such as Amylin Pharmaceuticals, CV Therapeutics, Inc., Sunesis Pharmaceuticals, and ALZA Corporation, where they held legal and managerial roles. Overall, Laturno has a strong background in legal and compliance matters within the pharmaceutical industry.

Camille Laturno has attended University of the Pacific - McGeorge School of Law and UC San Diego, but no degree or field of study information is provided for either institution.